Polymorphisms of SOCS-1 are associated with rapid HIV progression rate
Martin Hersberger, Erika Schlaepfer, Marco Buehler, Pierre-Yves Bochud, Pietro Vernazza, Jacqueline Marti-Jaun, Johannes Nemeth, Marcel Zwahlen, Kurt Schmidlin & Roberto F Speck
abstract
|
OBJECTIVES
Immune activation, among other driven by IFN-α and -γ
activation is a main feature of progressive HIV infection.
Suppressor of cytokine signaling (SOCS) 1 and 3 are negative
feedback regulators of the IFN-α and -γ axis. Here, we
analyzed the role of 9 single nucleotide polymorphisms (SNPs) within
SOCS-1 and 3 genes for their association with HIV progression rate
in a cohort of 318 rapid vs 376 slow progressors from the Swiss HIV
Cohort Study.
DESIGN
AND METHODS: We analyzed 9 SNPs, which we have identified in Swiss
blood donors, in a cohort of HIV-infected patients (n=1144), which
have been categorized according to the decline in CD4+ T-cell
counts. In all the conducted analyses, we focused on the comparison
between rapid and slow progressors with regard to SNPs in SOCS1 and
-3 and with regards to haplotypes using multivariate logistic
regression models.
RESULTS
Three SOCS-1 SNPs (rs193779; rs33989964; and rs4780355) are
associated with a risk reduction for rapid progression. Two of these
SNPs, rs33989964 and rs4780355, are in strong linkage disequilibrium
forming a frequent haplotype. Homozygous carriers of this haplotype
are also associated with a risk reduction for rapid progression. In
contrast, the minor TT genotype of rs33977706 is associated with
twice the risk for rapid progression. No associations have been
observed for the four SOCS-3 SNPs or the major SOCS-3
haplotypes.
CONCLUSION
Our data suggest that SNPS in SOCS-1 are associated with HIV disease
progression and speak in favor that immune activation is causal for
the progressive immunodeficiency.
|
|
|
citation
|
Hersberger M, Schlaepfer E, Buehler M, Bochud P Y, Vernazza P,
Marti-Jaun J, Nemeth J, Zwahlen M, Schmidlin K, Speck R F.
Polymorphisms of SOCS-1 are associated with rapid HIV progression
rate. J Acquir Immune Defic Syndr 2020;.
|
|
|
type
|
journal paper/review (English)
|
date of publishing
|
21-02-2020
|
journal title
|
J Acquir Immune Defic Syndr
|
ISSN electronic
|
1944-7884
|
PubMed
|
32097250
|
DOI
|
10.1097/QAI.0000000000002319
|
additional links & downloads